SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-005507
Filing Date
2008-08-11
Accepted
2008-08-11 16:01:45
Documents
8
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS, INC. b71170cte10vq.htm 10-Q 729685
2 EX-2.2 AMENDMENT NO.1, DATED AS OF AUGUST 7, 2008, TO AGREEMENT AND PLAN OF MERG b71170ctexv2w2.htm EX-2.2 12045
3 EX-2.4 MERGER PARTNER NOTEHOLDER AGREEMENT, DATED AS OF MAY 1, 2008 b71170ctexv2w4.htm EX-2.4 53607
4 EX-2.5 AMENDMENT NO. 1, DATED AS OF AUGUST 7, 2008, TO MERGER PARTNER NOTEHOLDER b71170ctexv2w5.htm EX-2.5 13434
5 EX-31.1 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 b71170ctexv31w1.htm EX-31.1 8770
6 EX-31.2 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14 b71170ctexv31w2.htm EX-31.2 9534
7 EX-32.1 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. S b71170ctexv32w1.htm EX-32.1 3957
8 EX-32.2 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. S b71170ctexv32w2.htm EX-32.2 4499
  Complete submission text file 0000950135-08-005507.txt   836918
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 081006222
SIC: 2834 Pharmaceutical Preparations